1. Home
  2. PLX vs SIGA Comparison

PLX vs SIGA Comparison

Compare PLX & SIGA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Protalix BioTherapeutics Inc. (DE)

PLX

Protalix BioTherapeutics Inc. (DE)

SELL

Current Price

$2.90

Market Cap

207.1M

Sector

Health Care

ML Signal

SELL

Logo SIGA Technologies Inc.

SIGA

SIGA Technologies Inc.

SELL

Current Price

$2.41

Market Cap

223.8M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
PLX
SIGA
Founded
1993
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
207.1M
223.8M
IPO Year
1996
2016

Fundamental Metrics

Financial Performance
Metric
PLX
SIGA
Price
$2.90
$2.41
Analyst Decision
Buy
Analyst Count
2
0
Target Price
★ $12.00
N/A
AVG Volume (30 Days)
★ 990.1K
535.8K
Earning Date
11-10-2026
11-09-2026
Dividend Yield
N/A
★ 22.64%
EPS Growth
N/A
★ N/A
EPS
★ 0.31
0.09
Revenue
★ $52,744,000.00
N/A
Revenue This Year
$64.22
N/A
Revenue Next Year
N/A
$205.62
P/E Ratio
★ $9.85
$29.56
Revenue Growth
N/A
★ N/A
52 Week Low
$1.65
$2.51
52 Week High
$3.19
$7.11

Technical Indicators

Market Signals
Indicator
PLX
SIGA
Relative Strength Index (RSI) 56.51 28.24
Support Level $2.08 N/A
Resistance Level $3.19 $3.43
Average True Range (ATR) 0.20 0.24
MACD 0.03 -0.06
Stochastic Oscillator 71.74 1.21

Price Performance

Historical Comparison
PLX
SIGA

About PLX Protalix BioTherapeutics Inc. (DE)

Protalix BioTherapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, production, and commercialization of therapeutics for rare diseases with important unmet needs. ProCellEx, a proprietary plant cell-based protein expression system, represents a new method for developing recombinant proteins in an industrial-scale manner. corporate includes the development of treatments for rare and orphan diseases. The Company operates as a single operating segment in Israel.

About SIGA SIGA Technologies Inc.

SIGA Technologies Inc a commercial-stage pharmaceutical company. The Company sells its product, TPOX oral TPOXX, also known as tecovirimat, Tecovirimat-SIGA, or TEPOXX (tecovirimat) in certain international markets, to the U.S. Government and international governments (including government-affiliated entities). The Company operates in one single operating and reportable segment, which includes all activities related to the sale of the Company's Oral and IV TPOXX as well as research and development services.

Share on Social Networks: